Name & Company Information Location Interests
user-icon

Shruti Abbato

Celdara Medical, LLC

VP of Business Development

Lebanon

New Hampshire

United States

Interest Area>Biologics, Interest Area>Partnering
user-icon

Rebecca Abbott

March of Dimes

Director, Public Policy

Washington

Washington

United States

user-icon

Thierry Abribat

6023B15F-5FFA-47BA-8382-AACE4A28211C

Amesh Adalja

Johns Hopkins Center for Health Security

Senior Scholar

Interest Area>Infectious Diseases & Vaccines, Session Tracks>Infectious Disease And Vaccines
RAdami

Roger Adami

Nitto BioPharma Inc.

Senior Director

San Diego

California

United States

Interest Area>Biologics, Interest Area>Biomanufacturing, Interest Area>Drug Delivery, Interest Area>Gene Editing, Interest Area>Next Generation Bioetherapeutics, Interest Area>Partnering, Interest Area>Personalized Medicine & Diagnostics, Interest Area>Preclinical/Research, Interest Area>Therapeutics, Product Focus Zone/Special Pavilion>Innovation Zone, Session Tracks>Business Development And Finance, Session Tracks>Next Generation Biotherapeutics, Session Tracks>Oncology, Session Tracks>Personalized Medicine And Diagnostics
user-icon

Cyrus Agarabi

U.S. Food and Drug Administration

Principal Investigator/Research/Review Officer/CDR

Session Tracks>Regulatory Innovation
630953-23012079-898a-4c77-9380-033cb2306177

Dr. Ankit Agarwal

Imbed Biosciences Inc.

CEO

Madison

Wisconsin

United States

Interest Area, Interest Area>Business Development & Finance, Interest Area>Drug Delivery, Interest Area>Emerging Opportunities In Global Markets, Interest Area>Medical Devices, Interest Area>Opioids, Interest Area>Pain Management, Interest Area>Partnering, Interest Area>Regenerative Medicine, Interest Area>Tissue Engineering, Product Focus Zone/Special Pavilion, Product Focus Zone/Special Pavilion>Innovation Zone, Session Tracks, Session Tracks>Emerging Opportunities In Global Markets, Session Tracks>Opioids: Changing The Paradigm On Treating Pain And Addiction, Session Tracks>Regulatory Innovation, Session Tracks>Translational Research, Session Tracks>Value‚ Patient Access And Reimbursement
674213-cd4ce45f-ebb7-4016-9e15-1d10ba553380

Sonalee Agarwal

Alnylam Pharmaceuticals

VP Value Evidence & Strategy

Cambridge

Massachusetts

United States

Interest Area>Business Development & Finance, Interest Area>CNS/Neurological, Interest Area>Central Nervous System, Interest Area>Diagnostics, Interest Area>Digital Health, Interest Area>Emerging Opportunities In Global Markets, Interest Area>Gene Editing, Interest Area>Gene/Cell Therapy, Interest Area>Genetic Disorders, Interest Area>Genomics, Interest Area>Neurological Disease, Interest Area>Orphan & Rare Diseases, Interest Area>Patient Advocacy, Interest Area>Pharmacogenomics, Product Focus Zone/Special Pavilion>BIO Member Services Pavilion, Session Tracks>Brain Health, Session Tracks>Business Development And Finance, Session Tracks>Digital Health, Session Tracks>Emerging Opportunities In Global Markets, Session Tracks>Genome Editing, Session Tracks>Oncology, Session Tracks>Orphan And Rare Diseases, Session Tracks>Patient Advocacy, Session Tracks>Value‚ Patient Access And Reimbursement
user-icon

Sam Agresta

Infinity Pharmaceuticals

Chief Medical Officer

Cambridge

Massachusetts

United States

user-icon

Dr. Andrew Aherrera

Cugene Inc.

Head of Business Development

Waltham

Massachusetts

United States

user-icon

Mr. Jaeyoung Ahn

VORONOI Inc.

Head of BD

Incheon

Korea, Republic of

545055-9fecb268-4303-4a8a-bf1c-dfb208ec3e81

Murray Aitken

IQVIA Institute for Human Data Science

Executive Director

New York

New York

United States

674569-59feee58-199f-49f1-a57e-47bbc897b724

Nsikan Akpan

PBS Newshour

Digital Science Producer, PBS News Hour

user-icon

Amirah Al Idrus

FierceBiotech

Editor

Washington

Washington

United States

544193-07f79335-d052-4d7b-9d3f-764423bf635c

Dr. Wendy Alderton

Cambridge University, UK

Cancer Research UK Cambridge Centre Early Detection Programme Manager

Cambridge

Cambridge

United Kingdom

Interest Area>Molecular Diagnostics, Interest Area>Oncology, Interest Area>Translational Research, Session Tracks>Oncology
666561-4dca1426-3575-4b25-9353-defd469fb2b9

Ron Alfa

Recursion Pharmaceuticals

Senior Vice President, Translational Discovery

Salt Lake City

Utah

United States

Alferman_1443_2

Jim Alferman

Sekisui

Associate Director, Business Development

St. Louis

Missouri

United States

Diagnostics/Device/Digital Health>Drug Delivery Device, Diagnostics/Device/Digital Health>Molecular/Cellular Diagnostics, Diagnostics/Device/Digital Health>Non-Molecular Diagnostics, Interest Area>Biologics, Interest Area>Biomanufacturing, Interest Area>Diagnostics, Interest Area>Molecular Diagnostics, Interest Area>Next Generation Bioetherapeutics, Interest Area>Partnering, Product Focus Zone/Special Pavilion>Contract Services Zone, Service>CMO, Session Tracks>Next Generation Biotherapeutics
user-icon

Dr. Khatija Ali

BioSapien Inc

CEO

Brooklyn

New York

United States

401550

Debbie Allen

arGEN-X

Senior Vice President Business Development

Zwijnaarde-Gent

Belgium

Interest Area>Autoimmune Disease, Interest Area>Biologics, Interest Area>CNS/Neurological, Interest Area>Hematology, Interest Area>Immune Disorder, Interest Area>Neurological Disease, Interest Area>Therapeutics
Allgood-Chalkboard-sqr

Brandon Allgood

Numerate

CTO

San Francisco

California

United States

Interest Area>Brain Health, Interest Area>CNS/Neurological, Interest Area>Cardiovascular, Interest Area>Genomics, Interest Area>Inflammatory Disease, Interest Area>Neurological Disease, Interest Area>Renal, Interest Area>Small Molecules, Interest Area>Therapeutics, Interest Area>Translational Research, Session Tracks>Brain Health, Session Tracks>Digital Health, Session Tracks>Translational Research
user-icon

Niva Almaula

Actinium Pharmaceuticals, Inc.

Chief Business Officer

New York

New York

United States

user-icon

Cambria Alpha-Cobb

Momenta Pharmaceuticals

Patent Agent

Boston

Massachusetts

United States

Interest Area>Intellectual Property, Session Tracks>Intellectual Property
395419

Dr. Michael Altorfer

Swiss Biotech Association

CEO

Zürich

Zürich

Switzerland

Interest Area>Biologics, Interest Area>Biomanufacturing, Interest Area>Business Development & Finance, Interest Area>CNS/Neurological, Interest Area>Cardiovascular, Interest Area>Central Nervous System, Interest Area>Contract Research Organization, Interest Area>Diagnostics, Interest Area>Digital Health, Interest Area>Drug Delivery, Interest Area>Gene Editing, Interest Area>Gene/Cell Therapy, Interest Area>Hematology, Interest Area>Imaging, Interest Area>Immune Disorder, Interest Area>Immunology, Interest Area>Infectious Diseases & Vaccines, Interest Area>Inflammatory Disease, Interest Area>Intellectual Property, Interest Area>Molecular Diagnostics, Interest Area>Neurological Disease, Interest Area>Next Generation Bioetherapeutics, Interest Area>Non-Profit/Patient Advocacy Group, Interest Area>Oncology, Interest Area>Orphan & Rare Diseases, Interest Area>Partnering, Interest Area>Personalized Medicine & Diagnostics, Interest Area>Preclinical/Research, Interest Area>Regenerative Medicine, Interest Area>Regulatory Innovation, Interest Area>Regulatory Science, Interest Area>Small Molecules, Interest Area>Stem Cell Research, Interest Area>Therapeutics, Interest Area>Tissue Engineering, Product Focus Zone/Special Pavilion>Innovation Zone, Session Tracks>Business Development And Finance, Session Tracks>Digital Health, Session Tracks>Genome Editing, Session Tracks>Infectious Disease And Vaccines, Session Tracks>Intellectual Property, Session Tracks>Next Generation Biotherapeutics, Session Tracks>Oncology, Session Tracks>Orphan And Rare Diseases, Session Tracks>Personalized Medicine And Diagnostics, Session Tracks>Regulatory Innovation
20180110_IUSM_NJAlves_this one

Prof. Nathan Alves

Indiana Lysis Technologies

President and CEO

Indianapolis

Indiana

United States

Academic/Non-Profit>University (Faculty), Diagnostics/Device/Digital Health>Molecular/Cellular Diagnostics, Interest Area>Biologics, Interest Area>Biomanufacturing, Interest Area>Business Development & Finance, Interest Area>Diagnostics, Interest Area>Drug Delivery, Interest Area>Hematology, Interest Area>Immunology, Interest Area>Intellectual Property, Interest Area>Medical Devices, Interest Area>Microfluidics, Interest Area>Molecular Diagnostics, Interest Area>Next Generation Bioetherapeutics, Interest Area>Partnering, Interest Area>Preclinical/Research, Interest Area>Research Tools, Interest Area>Therapeutics, Interest Area>Translational Research, Session Tracks>Intellectual Property, Session Tracks>Next Generation Biotherapeutics, Session Tracks>Translational Research
624892-407bebba-12ba-4db6-9488-fc7f03cb7cfe

David Anderson

Spark Therapeutics

CNS Research Lead

Philadelphia

Pennsylvania

United States

544533-bea5e4d9-8cb9-4652-b03d-3037d009edd5

Mr. Django Andrews

Sarepta Therapeutics, Inc.

Director, Sr. Patent Counsel

Cambridge

Massachusetts

United States

639734-b23c5871-ab3a-4997-b3a0-8756a8da1587

Mark Angelicola

Otsuka Pharmaceutical Companies (U.S.)

Senior Manager, Clinical Management

Interest Area, Interest Area>CNS/Neurological, Interest Area>Digital Health, Interest Area>Mental Health, Session Tracks, Session Tracks>Digital Health, Session Tracks>Next Generation Biotherapeutics, Session Tracks>Patient Advocacy
382488

Mr. William Annett

OncoCyte Corporation

CEO

Alameda

California

United States

user-icon

Paula Annunziato

Merck & Co., Inc.

VP, Clinical Research, GCD, Vaccines

613704-58db9718-4867-4ece-b5e4-8eb5ce708877

Christopher Anselmo

Muscular Dystrophy Association

Market Intelligence Manager

Westbrook

Connecticut

United States

user-icon

Maria Apostolaros

PhRMA - Pharmaceutical Research & Manufacturers of America

Sr. Director, SRA

Washington

District of Columbia

United States

Academic/Non-Profit>Associations, Interest Area>Regulatory Innovation, Interest Area>Regulatory Science, Interest Area>Research Tools, Service>Legal, Session Tracks>Brain Health, Session Tracks>Intellectual Property, Session Tracks>Next Generation Biotherapeutics, Session Tracks>Oncology, Session Tracks>Regulatory Innovation
401539

Anjan Aralihalli

GLyPharma Therapeutic; CTI Life Sciences Fund II

Chief Business Officer; Venture Partner

MOntreal

Quebec

Canada

user-icon

Simon Arkell

Deep Lens

President

Columbus

Ohio

United States

headshot

John Armando

Biogen

Manager, Global Regulatory Affairs CMC

Cambridge

MA

United States

Interest Area>Biologics, Interest Area>Biomanufacturing, Interest Area>CNS/Neurological, Interest Area>Emerging Opportunities In Global Markets, Interest Area>Neurological Disease, Interest Area>Next Generation Bioetherapeutics, Interest Area>Regulatory Innovation, Interest Area>Regulatory Science, Product Focus Zone/Special Pavilion>Innovation Zone, Session Tracks>Emerging Opportunities In Global Markets, Session Tracks>Next Generation Biotherapeutics, Session Tracks>Regulatory Innovation
user-icon

Dr. Jon Arnason

Beth Israel Deaconess Medical Center

Harvard Medical Faculty Physician, Hematology/Oncology

userPhoto

Phyllis Arthur

Biotechnology Innovation Organization (BIO)

Vice President, Infectious Diseases and Diagnostics Policy

Washington

District Of Columbia

United States

Interest Area>Emerging Opportunities In Global Markets, Interest Area>Gene Editing, Interest Area>Gene/Cell Therapy, Interest Area>Immunology, Interest Area>Infectious Diseases & Vaccines, Interest Area>Molecular Diagnostics, Interest Area>Personalized Medicine & Diagnostics, Interest Area>Regenerative Medicine, Session Tracks>Emerging Opportunities In Global Markets, Session Tracks>Genome Editing, Session Tracks>Infectious Disease And Vaccines, Session Tracks>Personalized Medicine And Diagnostics
userPhoto

Fredrik Aslund

EPO

Team Manager

Munich

Germany

user-icon

Anil Asnani

LabCorp

VP

Burlington

North Carolina

United States

Icon

Dr. Hartley Atkinson

AFT Pharmaceuticals

CEO

Takapuna

Takapuna

New Zealand

Interest Area, Interest Area>Emerging Opportunities In Global Markets, Interest Area>Highly Prevalent Chronic Diseases, Interest Area>Inflammatory Disease, Interest Area>Intellectual Property, Interest Area>Medical Devices, Session Tracks, Session Tracks>Emerging Opportunities In Global Markets, Session Tracks>Highly Prevalent Chronic Diseases, Session Tracks>Infectious Disease And Vaccines, Session Tracks>Intellectual Property, Session Tracks>Opioids: Changing The Paradigm On Treating Pain And Addiction, Session Tracks>Orphan And Rare Diseases, Session Tracks>Regulatory Innovation
user-icon

Jessica Atkinson

Foundation Medicine

Vice President, Corporate and Business Development

Cambridge

Massachusetts

United States

619245-58f6d4cd-a3d4-4a99-ac1b-a400a75df7eb

Jim Audia

Chicago Biomedical Consortium

Executive Director

Evanston

Illinois

United States

Academic/Non-Profit>Tech Transfer, Academic/Non-Profit>University (Faculty), Interest Area>Central Nervous System, Interest Area>Neurological Disease, Interest Area>Non-Profit/Patient Advocacy Group, Interest Area>Oncology, Interest Area>Partnering, Interest Area>Preclinical/Research, Interest Area>Research Tools, Interest Area>Screening, Interest Area>Small Molecules, Interest Area>Therapeutics, Interest Area>Translational Research, Session Tracks>Brain Health, Session Tracks>Oncology, Session Tracks>Translational Research
614788-da5d4b8c-401f-468e-9fdc-2b567388cc08

Christopher Austin

National Institutes of Health

Director, National Center for Advancing Translational Sciences (NCATS)

Bethesda

Maryland

United States

user-icon

Mr. Manohar B N

Stempeutics Research Pvt. Ltd.

Managing Director & CEO

Morrisville

North Carolina

United States

Interest Area>Gene/Cell Therapy, Interest Area>Stem Cell Research
542891-22880472-517b-48a0-80d1-56b84011c43e

Mr. John Babitt

EY

Partner

New York

New York

United States

Baer.Photo.Dec2015

Gerri Baer

U.S. Food and Drug Administration

Medical Officer, Neonatology Team Leader

Silver Spring

Maryland

United States

Interest Area>Central Nervous System, Interest Area>Drug Delivery, Interest Area>Medical Devices, Interest Area>Orphan & Rare Diseases, Interest Area>Preclinical/Research, Interest Area>Regulatory Innovation, Interest Area>Regulatory Science, Interest Area>Therapeutics, Interest Area>Translational Research, Session Tracks>Digital Health, Session Tracks>Orphan And Rare Diseases, Session Tracks>Regulatory Innovation, Session Tracks>Translational Research
user-icon

Ms. Blanca Baez

Molecular Health

SVP, Global Health of Pharma & Biotech

Boston

Massachusetts

United States

Interest Area>Biologics, Interest Area>Business Development & Finance, Interest Area>CNS/Neurological, Interest Area>Cell Biology, Interest Area>Contract Research Organization, Interest Area>Degeneration, Interest Area>Digital Health, Interest Area>Immunology, Interest Area>Inflammatory Disease, Interest Area>Mental Health, Interest Area>Molecular Diagnostics, Interest Area>Oncology, Interest Area>Personalized Medicine & Diagnostics, Interest Area>Pharmacogenomics, Interest Area>Proteomics, Interest Area>Small Molecules, Interest Area>Tissue Engineering, Interest Area>Translational Research, Product Focus Zone/Special Pavilion>BIO Member Services Pavilion, Product Focus Zone/Special Pavilion>Innovation Zone, Session Tracks>Business Development And Finance, Session Tracks>Digital Health, Session Tracks>Next Generation Biotherapeutics, Session Tracks>Oncology, Session Tracks>Personalized Medicine And Diagnostics, Session Tracks>Translational Research
614799-390b14db-02d9-4a21-9ec9-64f78d2e58cb

Richard Bagger

Celgene Corporation

Executive Vice President, Corporate Affairs and Market Access

Summit

New Jersey

United States

user-icon

Michael Bailey

AVEO Oncology

CEO

Cambridge

Massachusetts

United States

David head shot 2018 - cropped3

Mr. David Baker

Vallon Pharmaceuticals

President & CEO

Philadelphia

Pennsylvania

United States

Academic/Non-Profit>Foundation/Patient Advocacy, Interest Area>Brain Health, Interest Area>Business Development & Finance, Interest Area>CNS/Neurological, Session Tracks>Brain Health, Session Tracks>Digital Health, Session Tracks>Intellectual Property
Annette

Dr. Annette Bakker

Children’s Tumor Foundation

President

New York

New York

United States

Interest Area>Biologics, Interest Area>Business Development & Finance, Interest Area>Cell Biology, Interest Area>Central Nervous System, Interest Area>Contract Research Organization, Interest Area>Drug Delivery, Interest Area>Gene Editing, Interest Area>Gene/Cell Therapy, Interest Area>Genetic Disorders, Interest Area>Imaging, Interest Area>Mental Health, Interest Area>Next Generation Bioetherapeutics, Interest Area>Non-Profit/Patient Advocacy Group, Interest Area>Oncology, Interest Area>Opioids, Interest Area>Orphan & Rare Diseases, Interest Area>Pain Management, Interest Area>Partnering, Interest Area>Patient Advocacy, Interest Area>Personalized Medicine & Diagnostics, Interest Area>Preclinical/Research, Interest Area>Proteomics, Interest Area>Regulatory Innovation, Interest Area>Research Tools, Interest Area>Screening, Interest Area>Small Molecules, Interest Area>Therapeutics, Interest Area>Translational Research, Product Focus Zone/Special Pavilion>Innovation Zone, Product Focus Zone/Special Pavilion>Patient Advocacy Pavilion, Session Tracks>Business Development And Finance, Session Tracks>Genome Editing, Session Tracks>Oncology, Session Tracks>Orphan And Rare Diseases, Session Tracks>Patient Advocacy, Session Tracks>Translational Research